PulmonX's Line of Credit Round

PulmonX raised a round of funding on September 17, 2014. Investors include Oxford Finance.

PulmonX is engaged in the design, development and manufacture of products to deliver effective endoscopic lung volume reduction (ELVR) to patients with emphysema-induced hyperinflation. ELVR involves …

Articles about PulmonX's Line of Credit Round: